Target WP5 - Ricapps

The network

research programme

02

WP 5. Diagnostic and therapeutic optimisation of prevalent diseases in primary care.

Coordinator

Alfonso Leiva

Research Group GRAPP-caIB

RD21/0016/0009

aleiva@ibsalut.es

Participating Groups

Cardiocat. IP:

Rafel Ramos (RD21/0001/0001)

BIPS. IP:

Alvaro Sanchez (RD21/0001/0003)

AQUAS. IP:

Mireia Espallargues (RD21/0001/0007)

GRAP-caIB. IP:

Alfonso Leiva (RD21/0001/0009)

Aragón - GAIAP. IP:

Rosa Magallón (RD21/0001/0005)

Valencia. IP:

Isabel Hurtado (RD21/0001/0006)

Canary Islands. IP:

Lilisbeth Perestelo (RD21/0001/0013)

Galicia. IP:

Francisco Gude (RD21/0001/0022)

Madrid-AP. IP:

César Minué (RD21/0001/0026)

GRenSSAP. IP:

Anna Berenguera (RD21/0001/0029)

Research lines

Line 1 To improve diagnostic decision-making in PHC through the development, evaluation and application of affordable and validated instruments, tools and devices to increase diagnostic accuracy in PHC. The objectives are to promote excellence in one of the most important determinants of subsequent medical interventions (e.g. treatments and referrals) and to involve patients as an integral part of the diagnostic process, not treating them as passive recipients and helping them to understand their symptoms.

Task 1. To develop and validate markers, technologies and instruments to improve performance and diagnostic reasoning in primary health care.

Task 2. To evaluate performance and implement into clinical practice effective and easy-to-use point-of-care tests to reduce diagnostic uncertainty and improve patients’ experiences and health outcomes.

Task 3. To develop diagnostic algorithms and toolkits for general practitioners in order to prevent diagnostic errors and reduce the harm resulting from incorrect or delayed diagnoses.

Line 2 To address the overuse and misuse of medicine in primary health care through the development and implementation of effective and cost-effective interventions to promote the appropriate use of health services and reduce the negative impact of non-beneficial care. The research projects will focus on the drivers of ineffective and low-value practices, and on providing evidence-based solutions to reduce harm to patients, the inefficient use of healthcare resources and waste in primary health care.

Task 1. To identify the drivers of overuse and misuse of medical services through analysis, better understanding and monitoring of the multifaceted and complex matrix of low-value practices.

Task 2. To plan, design and evaluate interventions to mitigate the negative impact of overuse and misuse of medical services on patients’ health outcomes, by promoting patient-centred decision-making and improving awareness and education among healthcare professionals, patients, families and carers.

Task 3. To develop and evaluate PHC-based strategies for the implementation of good clinical practices focused on improving the standardisation of care delivery in PHC and increasing the adoption rates of evidence-based clinical practices.

Task 4. To plan, design and evaluate interventions for the deprescribing and deimplementation of practices or treatments that do not have a positive impact on patients’ health outcomes, in order to improve patient safety and the appropriate use of primary care resources.

Line 3 To optimise the therapeutic care of common diseases in PHC, strengthening the effective and safe use of medicines and developing and evaluating non-pharmacological therapies to improve the clinical outcomes of common diseases in PHC. The objectives are to promote the provision of responsible, patient-centred therapeutic care, to improve the use of self-management plans and new technologies, to reduce poor adherence, and to achieve a balance between managing a disease and medication-related problems.

Task 1. To develop and evaluate multifactorial interventions to improve medication adherence by leveraging data and technology and promoting sustained behaviour change among healthcare professionals and patients.

Task 2. To evaluate and compare the effectiveness of various treatments to increase the use of evidence-based medication processes, by analysing and reporting real-world data on prescription patterns in PHC, optimising patient adherence and reducing prescription errors.

Task 3. To plan, design and evaluate non-pharmacological interventions to reduce prescriptions and improve patients’ health outcomes.

Task 4. To promote a culture of patient safety, by encouraging the delivery of safer care through the analysis of real-world data on exposure to medicines and the validation of instruments to improve the safety climate.